Exact Mass: 465.19736860000006
Exact Mass Matches: 465.19736860000006
Found 190 metabolites which its exact mass value is equals to given mass value 465.19736860000006
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
S9947
C29H27N3O3 (465.20523120000007)
Biotripyrrin-a
C25H27N3O6 (465.18997620000005)
Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247
Biotripyrrin-b
C25H27N3O6 (465.18997620000005)
Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247. These metabolites are recognized by an anti-bilirubin monoclonal antibody, 24G7, but are neg. in the diazo reaction. (PubMed ID 9836731 ). Biotripyrrin-a and biotripyrrin-b, bilirubin metabolites, are novel tripyrrole biocompounds and belong to a third group of bile pigments following biliverdin and bilirubin. They are regioisomers of each other. -- Yamaguchi T et al., J Biochem (Tokyo). 1994 Aug;116(2):298-303. PMID 7822247
Acalabrutinib
Benzylpenicilloyl G
C22H31N3O6S (465.19334660000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-{5-[(2,3,4,5,6-Pentamethylbenzyl)sulfanyl]-4-phenyl-4H-1,2,4-triazol-3-yl}-3-(2-pyridinyl)acrylonitrile
C28H27N5S (465.19870620000006)
Cys Asp Lys Thr
Cys Asp Thr Lys
Cys Glu Lys Ser
Cys Glu Ser Lys
Cys Lys Asp Thr
Cys Lys Glu Ser
Cys Lys Ser Glu
Cys Lys Thr Asp
Cys Arg Ser Thr
Cys Arg Thr Ser
Cys Ser Glu Lys
Cys Ser Lys Glu
Cys Ser Arg Thr
Cys Ser Thr Arg
Cys Thr Asp Lys
Cys Thr Lys Asp
Cys Thr Arg Ser
Cys Thr Ser Arg
Asp Cys Lys Thr
Asp Cys Thr Lys
Asp Lys Cys Thr
Asp Lys Thr Cys
Asp Thr Cys Lys
Asp Thr Lys Cys
Glu Cys Lys Ser
Glu Cys Ser Lys
Glu Lys Cys Ser
Glu Lys Ser Cys
Glu Ser Cys Lys
Glu Ser Lys Cys
Phe Gly Gly Trp
C24H27N5O5 (465.20120920000005)
Phe Gly Trp Gly
C24H27N5O5 (465.20120920000005)
Phe Trp Gly Gly
C24H27N5O5 (465.20120920000005)
Gly Phe Gly Trp
C24H27N5O5 (465.20120920000005)
Gly Phe Trp Gly
C24H27N5O5 (465.20120920000005)
Gly Gly Phe Trp
C24H27N5O5 (465.20120920000005)
Gly Gly Trp Phe
C24H27N5O5 (465.20120920000005)
Gly Trp Phe Gly
C24H27N5O5 (465.20120920000005)
Gly Trp Gly Phe
C24H27N5O5 (465.20120920000005)
Lys Cys Asp Thr
Lys Cys Glu Ser
Lys Cys Ser Glu
Lys Cys Thr Asp
Lys Asp Cys Thr
Lys Asp Thr Cys
Lys Glu Cys Ser
Lys Glu Ser Cys
Lys Ser Cys Glu
Lys Ser Glu Cys
Lys Thr Cys Asp
Lys Thr Asp Cys
Met Asn Thr Thr
Met Gln Ser Thr
Met Gln Thr Ser
Met Ser Gln Thr
Met Ser Thr Gln
Met Thr Asn Thr
Met Thr Gln Ser
Met Thr Ser Gln
Met Thr Thr Asn
Asn Met Thr Thr
Asn Thr Met Thr
Asn Thr Thr Met
Gln Met Ser Thr
Gln Met Thr Ser
Gln Ser Met Thr
Gln Ser Thr Met
Gln Thr Met Ser
Gln Thr Ser Met
Arg Cys Ser Thr
Arg Cys Thr Ser
Arg Ser Cys Thr
Arg Ser Thr Cys
Arg Thr Cys Ser
Arg Thr Ser Cys
Ser Cys Glu Lys
Ser Cys Lys Glu
Ser Cys Arg Thr
Ser Cys Thr Arg
Ser Glu Cys Lys
Ser Glu Lys Cys
Ser Lys Cys Glu
Ser Lys Glu Cys
Ser Met Gln Thr
Ser Met Thr Gln
Ser Gln Met Thr
Ser Gln Thr Met
Ser Arg Cys Thr
Ser Arg Thr Cys
Ser Thr Cys Arg
Ser Thr Met Gln
Ser Thr Gln Met
Ser Thr Arg Cys
Thr Cys Asp Lys
Thr Cys Lys Asp
Thr Cys Arg Ser
Thr Cys Ser Arg
Thr Asp Cys Lys
Thr Asp Lys Cys
Thr Lys Cys Asp
Thr Lys Asp Cys
Thr Met Asn Thr
Thr Met Gln Ser
Thr Met Ser Gln
Thr Met Thr Asn
Thr Asn Met Thr
Thr Asn Thr Met
Thr Gln Met Ser
Thr Gln Ser Met
Thr Arg Cys Ser
Thr Arg Ser Cys
Thr Ser Cys Arg
Thr Ser Met Gln
Thr Ser Gln Met
Thr Ser Arg Cys
Thr Thr Met Asn
Thr Thr Asn Met
Trp Phe Gly Gly
C24H27N5O5 (465.20120920000005)
Trp Gly Phe Gly
C24H27N5O5 (465.20120920000005)
Trp Gly Gly Phe
C24H27N5O5 (465.20120920000005)
Sarpogrelate Hydrochloride
C24H32ClNO6 (465.19180420000004)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Sarpogrelate hydrochloride (MCI-9042) is a selective 5-HT2R antagonist, with pKis of 8.52, 6.57, and 7.43 for 5-HT2A, 5-HT2B, and 5-HT2C receptors, respectively. Sarpogrelate hydrochloride displays selectivity over 5-HT1, 5-HT3, 5-HT4, α1-, α2- and β-adrenoreceptor, histamine H1, H2 and muscarinic M3 receptors. Sarpogrelate hydrochloride can be used for the research of vascular disease associated with thrombosis[1][2][3].
TERT-BUTYL 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE
C22H31N3O6S (465.19334660000004)
PF-543
C27H31NO4S (465.19736860000006)
D004791 - Enzyme Inhibitors
11-(PYRENE-1-SULFONYLAMINO)UNDECANOIC ACID
C27H31NO4S (465.19736860000006)
Acalabrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(1S,2R)-(-)-2-AMINOCYCLOHEX-3-ENECARBOXYLICACIDHYDROCHLORIDE
C27H31NO4S (465.19736860000006)
Tert-Butyl 4-({[4-(But-2-Yn-1-Ylamino)phenyl]sulfonyl}methyl)-4-[(Hydroxyamino)carbonyl]piperidine-1-Carboxylate
C22H31N3O6S (465.19334660000004)
(Z,Z)-2-[[3-(2-carboxyethyl)-5-[(4-ethenyl-1,5-dihydro-3-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylene]-2,5-dihydro-4-methyl-5-oxo-1H-Pyrrole-3-propanoate
C25H27N3O6 (465.18997620000005)
5-[[2-[4-[1-(1,3-Dioxo-2-indenylidene)ethyl]-1-piperazinyl]ethylamino]methylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione
C24H27N5O5 (465.20120920000005)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H28FN3O4 (465.20637400000004)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H28FN3O4 (465.20637400000004)
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
1-[(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C26H28FN3O4 (465.20637400000004)
1-[(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C26H28FN3O4 (465.20637400000004)
5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)
(1r,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)
n-(2-{2-[(4-hydroxy-1-methyl-2-oxoquinolin-3-yl)(phenyl)methyl]-1h-indol-3-yl}ethyl)ethanimidic acid
C29H27N3O3 (465.20523120000007)
(1s,4z,5s,6s,7s,11z)-5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)